206640.KQ KOE
Boditech Med Inc.
1W: +4.3%
1M: -3.3%
3M: -7.8%
YTD: -26.1%
1Y: -30.3%
3Y: -33.4%
5Y: -54.9%
₩9,750.00 ($7.26)
+50.00 (+0.52%)
Weekly Expected Move ±2.4%
₩9276
₩9513
₩9750
₩9987
₩10224
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$279.8B
+9.9% ▲
5Y CAGR: +11.3%
Total Liabilities
$35.6B
+12.6% ▲
5Y CAGR: -1.0%
Shareholders Equity
$231.3B
+10.0% ▲
5Y CAGR: +14.1%
Cash & Investments
$37.7B
-38.9% ▼
5Y CAGR: -8.6%
Total Debt
$17.7B
+60.1% ▲
5Y CAGR: +8.3%
Net Debt
-$1.8B
+95.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $38.8B | $26.3B | $42.5B | $47.9B | $19.6B |
| Short-Term Investments | $29.7B | $34.2B | $33.7B | $13.8B | $18.2B |
| Cash & ST Investments | $68.5B | $60.5B | $76.2B | $61.7B | $37.7B |
| Net Receivables | $27.0B | $24.3B | $26.5B | $32.2B | $39.0B |
| Inventory | $33.4B | $30.8B | $31.6B | $38.8B | $40.7B |
| Other Current Assets | $1.8B | $1.3B | $4.0B | $143M | $3.3B |
| Total Current Assets | $131.1B | $117.3B | $138.7B | $135.8B | $120.7B |
| Property, Plant & Equip. | $45.4B | $58.2B | $56.4B | $61.9B | $86.9B |
| Goodwill & Intangibles | $4.5B | $5.4B | $4.1B | $6.1B | $6.1B |
| Long-Term Investments | $9.5B | $11.7B | $23.6B | $32.5B | $64.7B |
| Other Non-Current Assets | $259M | $1.6B | $5.1B | $16.3B | $1.4B |
| Total Non-Current Assets | $61.2B | $78.3B | $89.2B | $118.9B | $159.1B |
| Total Assets | $192.2B | $195.7B | $227.9B | $254.7B | $279.8B |
| — Liabilities — | |||||
| Accounts Payable | $6.4B | $1.6B | $5.2B | $5.5B | $3.6B |
| Short-Term Debt | $3.5B | $5.0B | $7.3B | $7.0B | $5.2B |
| Deferred Revenue | $1.3B | $1.1B | $0 | $0 | $0 |
| Other Current Liabilities | $10.6B | $2.7B | $8.6B | $8.4B | $11.9B |
| Total Current Liabilities | $27.1B | $16.1B | $27.3B | $27.4B | $21.5B |
| Long-Term Debt | $1.6B | $2.3B | $2.1B | $1.8B | $11.3B |
| Other Non-Current Liab. | $379M | $481M | $48M | $552M | $1.0B |
| Total Non-Current Liabilities | $3.9B | $4.7B | $3.2B | $4.2B | $14.1B |
| Total Liabilities | $31.0B | $20.8B | $30.5B | $31.6B | $35.6B |
| — Equity — | |||||
| Common Stock | $23.5B | $23.5B | $23.5B | $23.5B | $23.5B |
| Retained Earnings | $119.7B | $139.2B | $161.6B | $186.2B | $204.6B |
| Accumulated OCI | $2.8B | $2.8B | $1.3B | $5.1B | -$15.8B |
| Total Stockholders Equity | $151.1B | $163.6B | $186.2B | $210.3B | $231.3B |
| Total Liabilities & Equity | $192.2B | $195.7B | $227.9B | $254.7B | $279.8B |
| — Key Metrics — | |||||
| Total Debt | $6.9B | $8.9B | $10.6B | $11.1B | $17.7B |
| Net Debt | -$32.0B | -$17.4B | -$31.9B | -$36.9B | -$1.8B |
| Total Investments | $39.2B | $45.9B | $57.3B | $46.2B | $82.9B |